Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment

The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer. The main question it aims to answer are: * Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality? Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio

Trial Details

NCT ID

NCT06346080

Phase

NA

Sponsor

KU Leuven

Status

RECRUITING

Cancer Type

Gastric Cancer

Interventions

• Survey

Locations (sample)

• Leuven, Belgium|50.87959,4.70093

Key Eligibility Criteria

• Individuals \>18yo to 75yo (upper age limit of Barrett's surveillance)
• Access to computer or smartphone
• Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →